Since the discovery of the first case of AIDS in the 1981 report, this terrible disease has so far caused more than 25 million deaths and has become one of the most lethal diseases in human history. Tomorrow (December 1st) is the "World AIDS Day." Under the theme of "defending AIDS and fulfilling its promises," the whole society is launching an unprecedented AIDS fight. The latest World AIDS Report issued by the UNAIDS and the World Health Organization also praised China’s anti-AIDS work on the grounds that we have used limited funds for major AIDS prevention projects and achieved results.
Scientists "take pictures" of anti-enzymes: In a recent issue of the Journal of the American Journal of Biochemistry, researchers from the University of Rochester Medical Center in the United States introduced that scientists have taken pictures of why certain people are naturally resistant to HIV. A "snapshot" of the structure of the enzyme, which mutates the HIV virus and causes death. Scientists hope to invent a new drug to help humans fight against HIV.
AIDS Vaccine: China's first AIDS vaccine has completed phase I clinical trials in June this year. According to the current clinical observations, the safety of the vaccine is confirmed and the experiment is expected to enter phase II. The clinical study of the vaccine, once tested in all three phases, can be approved for production and application.
Anti-Ai drugs: After experts discovered that the Chinese medicine Glycyrrhiza has anti-Ai effects, several experts from the Guangzhou University of Traditional Chinese Medicine completed a research project funded by the Natural Science Foundation of Guangdong Province on a few days ago and showed that the extract of Polygonum cuspidatum Resveratrol has certain anti-AIDS The role of the virus; an expert from the Rena Medical Center in the UK also recommended a new Chinese medicine for the treatment of AIDS, the "Axis Anti-Virus Capsules", at the University of Rena Medical Center. The drug developed jointly by the Pharmaceutical Science and Technology Development Corporation began clinical trials in the United Kingdom in May 2005. After more than one year of clinical research, the drug has a good effect on the treatment of AIDS. Therefore, the drug is expected to serve as an alternative medicine after the failure of Western medicine.